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Abstract.  The TRM1 gene of Saccharomyces 
cerevisiae  encodes a  tRNA modification enzyme, 
N2,N2-dimethylguanosine-specific tRNA methyltransf-er- 
ase, which modifies both rnitochondrial and cytoplas- 
mic tRNAs.  The enzyme is targeted to mitochondria 
for the modification of mitoehondrial tRNAs.  Cellular 
fractionation and indirect immunofluorescence studies 
reported here demonstrate that this enzyme is also 
localized to the nucleus.  Further,  immunofluorescence 
experiments using strains that overproduce the enzyme 
show a  staining at the periphery of the nucleus suggest- 
ing that the enzyme is found in a  subnuclear destination 
near or at the nuclear membrane.  There is no obvious 
cytoplasmic staining in these overproducing strains. 
Fusion protein technology was used to begin to local- 
ize sequences involved in the nuclear targeting of this 
enzyme. Indirect immunofluorescence studies indicate 
that sequences between the first 70 and 213  NH2-ter- 
minal amino acids of the methyltransferase are suffici- 
ent to target Escherichia coli/3-galactosidase  to nuclei. 
p 
l~IUARV transcripts of tRNA genes undergo diverse 
posttranscriptional reactions during their maturation. 
A large proportion of these processing steps result in 
the modification of specific nucleoside residues with the ma- 
jority of the modifications being methylation reactions. Al- 
though the biological roles of these  methylations are  not 
clearly defined, the methylated nucleosides account for 30- 
70% of the modified nucleosides in tRNA (Nau, 1976). Mi- 
tochondrial and cytoplasmic tRNAs have different but over- 
lapping populations of methylated bases (Martin et al., 1976). 
Therefore, enzymes that are required for the synthesis of the 
methylations unique to each type of cellular RNA are likely 
specifically targeted to either mitochondria or the nucleus/ 
cytoplasm to function. Enzymes responsible for the synthe- 
sis of the same modified bases in both mitochondrial and cy- 
toplasmic tRNAs could either be  functionally related but 
structurally distinct isozymes or they could be structurally 
identical but found in multiple cellular locations. 
trm/  is a  nuclear mutation that affects N2,N2-dimethyl - 
guanosine (m~,G)  I biosynthesis of both mitochondrial and 
cytoplasmic tRNAs in Saccharomyces cerevisiae (Hopper et 
al., 1982).  Strains carrying the mutation and thus unable to 
make m~G, do not show any noticeable phenotype. We have 
previously reported the isolation of the TRM/gene and dem- 
onstrated that it encodes m~2G-specific tRNA methyltransfer- 
ase (Ellis et al., 1986). Two forms of  the enzyme can be made 
from this gene because some mRNAs transcribed from this 
1.  Abbreviations used in  this paper:  ~-gal, /~-galactosidase;  DAPI, 4',6'- 
diamidino-2-phenylindole; m]G, N2,N2-dimethylguanosine. 
gene include two AUGs separated by 15 codons while other, 
shorter mRNAs have only the second AUG from which to ini- 
tiate protein synthesis (Ellis et al., 1987). Enzyme synthesized 
from either the first or second AUG can be imported into mi- 
tochondria for m2,G base modification. The m2~G base modi- 
fication of cytoplasmic tRNAs appears to be carried out large- 
ly by enzyme synthesized from the second AUG (Ellis et 
al.,  1987). 
Methylation of nucleosides represents a major modifica- 
tion step in tRNA maturation. Although at least eight distinct 
methylation enzymes have been identified in S. cerevisiae, 
very little is known about the intracellular locations of these 
enzymes (Bjork and Svensson, 1969). The fact that some mi- 
tochondrial tRNAs contain meG suggests that the enzyme 
must be found in mitochondria, a supposition supported by 
the identification of NH2-terminal sequences that are suffi- 
cient to target passenger proteins to mitochondria (Ellis et 
al., 1989). Biochemical evidence indicates that nuclear pre- 
cursor tRNAs contain m~G, and they are believed to be nu- 
clear  restricted  (Peebles  et  al.,  1979;  Nishikura and De 
Robertis,  1981). This suggests that the enzyme responsible 
for this modification must be imported into the nucleus. It 
was not known whether the enzyme is also located in the 
cytoplasm. 
Cell  fractionation and indirect immunofluorescence ex- 
periments demonstrate that m2~G-specific tRNA methyltrans- 
ferase is a  nuclear enzyme in yeast. Specific nuclear rim 
staining is observed in strains that overproduce the enzyme, 
suggesting that the enzyme is at special subnuclear locations, 
possibly on or close to the nuclear membrane. Gene fusion 
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of the enzyme contain sufficient information to target/3-galac- 
tosidase (B-gad) to both the nucleus and mitoehondria. Since 
a fusion protein containing only the NH2-terminal 70 amino 
acids of the modification enzyme are not targeted to nuclei, 
we infer that the region between amino acid 70 and 213 of 
this enzyme contains sufficient information to target/3-gal to 
the yeast nucleus and have identified a stretch of amino acids 
in this region that are similar to other known nuclear target- 
ing signals. 
Materials and Methods 
Strains and Media 
Strains  used  in  these experiments were MH41-7B  (MATa,  ade2,  hisl), 
W303-1b (MATa, ade2-1, his3-11~15, 1eu2-3/112, ura3-1, trpl-1, canl-lO0), 
SNI015-2a (MAT~ SUP4, trml, trm2, gall, gall, ade2-1,/eul, ura3, met, 
lys2-1, trp, ura3-1), W303-1bTHT (a strain carrying a disrupted allele of the 
TRM/gene), DB745 (h/s4, leu2-3, ura3, ade2-1), and SEY2101  (MATa, 
ura3-52,  1eu2-31112, suc2-9, his4-519,  gal2). 
Plasmids 
HC-3 is a Yep24-TRMI recombinant plasmid which supports the synthesis 
of two forms of m2G-specific tRNA methyitransferase differing by 16 NH2- 
terminal amino acids because two in-frame ATGs are present in the gene 
and both are used (Ellis et al., 1986). A TRMI gene, altered by site-directed 
mutagenesis to introduce a Hind III site at position 8, was cloned into the 
Hind III site of pBM2"/2 which contains the Gall-Gall0 promoter region 
(Johnston and Davis, 1984).  The first ATG is upstream of the Hind III site 
so that synthesis of m]G-specific tRNA methyltransferase is from only the 
second ATG of the wild-type TRM1 gene in the resulting plasmid, pGT554. 
TRMI-LacZ fusion genes were produced by cloning an ECO RI/Bam HI 
fragment containing the  TRM/  promoter, both  in-frame ATGs,  and 213 
codons counted from the first ATG (Ellis et al., 1987) into the Eco RI/Bam 
HI sites of the vector, pSEYI01  (Emr et al., 1986).  The resulting plasmid, 
pTRMZ213,  generates chimeric proteins 1-213 TRMI  and  17-213 TRMI 
derived from the first or second in-frame ATG, respectively. Both have/3-gal 
activity.  Plasmid pTRMZ70 was derived from pTRMZ213  by deleting a Bgl 
II/Bam HI fragment. This deleted TRM/sequence codes for amino acids 
71 to 213 and thus the plasmid generates chimeric proteins 1-70 TRM1 and 
17-70 TRMI with/~-gal activity but containing fewer amino acids derived 
from the TRM/sequence than those proteins derived from pTRMZ213.  An 
identical strategy was used to construct plasmids that would synthesize only 
17-213 TRMI and 17-70 TRM1 proteins by using a TRM/gene in which the 
first ATG had been altered by site-directed mutagenesis (Ellis et al., 1987). 
The plasmid pLG669Z produces authentic/~-gal (Guarente et al.,  1982). 
All plasmids were introduced into yeast by the method of Ito et al. (1983). 
DNAs from yeast transformants were prepared using the procedure devel- 
oped by Zakian and Scott (1982) and confirmed either by restriction analysis 
or by DNA sequencing (Sanger et al.,  1977). 
Preparation of Crude Extracts for the mZ~G-specific 
tRNA Methyltransferase Assay and Western Blot 
Yeast strain DB745 carrying pGT554 was grown in either YPD(glucose) or 
YPGD(galactose) medium. Other strains were grown in media minus uracil 
(Hopper et al.,  1982)  and extracts prepared as described by Silver et al. 
(1984).  Briefly, when the optical density of the culture reached 1.00D~00, 
cells were harvested by  centrifugation,  washed with NET-NP(150  mM 
NaCi,  5 mM EDTA, 50 mM Tris-HCl, pH 7.4, 0.5%  NP-40), and sus- 
pended in NET-NP buffer containing 1 mM PMSF. Glass beads were added 
to the suspension and mixed on a vortex mixer at maximum speed for five 
30-s intervals separated by cooling in ice. After centrifugation at 15000 g 
for 1 min, the supernatant was saved. Protein concentrations were deter- 
mined using the method of Bradford (1976).  m]G-specific tRNA methyl- 
transferase activity was measured as described previously (Ellis ct al., 1986). 
Western blots were done according to the procedure described by Tobin et 
al.  (1979). 
Antigen Preparation 
An oligopeptide of 15 amino acids, CNPIKNWGPKARPNTS, predicted 
from the COOH terminus of TRM/  was ordered from the Biochemistry 
Department,  University of Texas  Southwestern Medical Center (Dallas, 
TX). A Cys residue was added to the NH2-terminus for cross-linking of the 
peptide to keyhole limpet hemocyanin. The coupling reaction of the peptide 
to keyhole limpet hemocyanin was done with chemical cross-linkers (Lerner 
et al.,  1981) by Immnno-Dynamics, Inc. (La Jolla, CA). 
Antibody Production 
New Zealand white male rabbits were immunized according to the proce- 
dure of Lerner et al. (1981). Two rabbits were injected subcutaneously on 
day 0, 14, 28, 42, and 49 with 0.8 nag of peptide-keyhole limpet hemocyanin 
conjugate. 0.5 ml of 1.6 mg/ml peptide in PBS was emulsified with 0.5 ml 
Freund's complete adjuvant (day 0) or incomplete adjuvant (day 14, 28, 42, 
and 49). Rabbits were bled first on day 35 and then 6-9 d after the booster 
injections on day 42 and 49. 
10-15 ml of sera were collected each time from each rabbit. Blood was 
set at room temperature for 1 h. The blood clot was rimmed and placed in 
the cold for 1 h and then centrifuged at 7,700 g for 5 rain. The serum was 
transferred into a clean centrifuge tube and again centrifuged for 5 min at 
7,700 g. The clear supernatant was then incubated at 560C for 30 min to 
denature the complement component of the serum. 
Affinity Purification of the Antipeptide Antibody 
Antibodies were purified by affinity chromatography. The peptide was cou- 
pled to CNBr-activated Sepharose 4B according to Livingston (1974).  1 ml 
of  the peptide-Sepbarose resin was placed in a column and equilibrated with 
50 ml buffer A containing 20 mM Tris-HCI, pH 7.5, and 100 mM NaCI. 
Antiserum was diluted  1:3  with buffer A  and loaded on the column by 
gravity.  The flow-through was recycled twice. After loading the serum, the 
column was washed extensively with 1 liter buffer A. The peptide-specific 
antibody was eluted with 10 ml of 0.2 M glycine, pH 2.2.  1-ml fractions 
of eluate were collected into an Eppendorf tube (Brinkmann Instruments 
Co., Westhury,  NY) containing 100 #1 of I M K2HPO4 to neutralize the pH 
immediately. Protein concentrations were determined by the method of 
Bradford (1976)  and the antibody quality  was assayed by Western blots 
(Tobin et al.,  1979). 
Preparation of  Enzyme Extracts for Inhibition Assays 
185 g of MH41-7B were suspended in 300 ml of buffer A containing 20 mM 
Tris-HCl, pH 7.5,  1 mM MgCI2,  1 mM EDTA, 25% ethylene glycol, 0.5 
mM benzamidine, 0.5 mM PMSF, and 10 mM/~-mercaptoethanol. The so- 
lution was decanted, mixed with (NI-L02SO4 to a final concentration of I M 
and Triton X-100 to a final 1% and stirred for 1 h at 4°C. Cells debris was 
removed by eentrifugation at 35,000 g for 15 min and the supernatant cen- 
trifuged at 100,000 g for 1 h. After centrifugation, the supernatant was dia- 
lyzed with several changes of buffer B overnight. Buffer B is the same as 
Buffer A except that the pH of the Tris-HCI is 8.0 instead of 7.5. More than 
80%  of the enzyme activity was recovered in the supernatant. 
A  1.5  x  10-cm DE53 column was packed and equilibrated with buffer 
B. The SI00 extract was loaded on the column at a flow rate of  5 ml/h. After 
loading, the column was washed with buffer B until the optical density of 
the eluate was <0.01 OD2s0. The enzyme was eluted from the column with 
a KC1 gradient between 0 and 500 mM in buffer B. Fractions containing 
enzyme activity were pooled and quickly frozen at -70°C. The enzyme was 
enriched 50-fold by this procedure. 
Enzyme Inhibition Assay 
1.25 #g of the enzyme extract prepared as described above was preincubated 
with purified antipeptide antibody on ice for 2 h. Total IgG protein was kept 
constant, but the ratio of immune IgG to preimmune IgG protein increased. 
The incubation mixture was then added to a premixed enzyme reaction solu- 
tion. All the remaining procedures were the same as described previously 
(Ellis et al.,  1986). 
Nuclear Fractionation 
The fractionation of extracts into nuclear and nonnuclear components was 
done according to Silver (1984).  300 ml (5  x  107 cells/ml) were harvested 
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0.5  mM  CaCI2,  0.5%  2-mercaptoethanol, 0.5  mM  PMSE  Zymolyase 
60,000 was added to a final concentration of 0.25 mg/ml, and incubated at 
room temperature until spheroplast formation occurred. Spheroplasts were 
spun down at 3,500 g for 3 min, and suspended in 2 ml lysis buffer contain- 
ing 0.2% NP-40,  10 mM Tris-HC1,  pH 7.4,  10 mM NaCI, 5 mM MgCI2, 
0.5  mM  CaCl2,  0.5  mM  PMSE  15  strokes in  a  Dounce homogenizer 
(Kontes Glass Co., Vineland, NJ) were used to lyse the spheroplasts. 
Crude nuclei were collected by centrifugation at 3,000 g for 5 min and 
suspended in 30 ml of 50% (wt/vol) percoll, 40 mM Pipes, pH 6.8, 10 mM 
MgCi2, 0.5 mM PMSF, 0.05% Triton X-100. The suspension was then cen- 
trifuged at 21,000 g for 35 min in a Ti-30 rotor. The nuclear band was har- 
vested and the nuclei pelleted at 5,000 g after diluting the percoil solution 
10-fold with 0.01 M  K2HPO4-KH2PO4,  pH 6.5. 
~-Galactosidase Assay 
Assays  for  ~-galactosidase were  done  according to  Miller's  procedure 
(Miller, 1972) with some modifications specific for yeast. 0.1-1 ml of yeast 
culture with an optical density of I OD~00 was mixed with 2 vol of Z buffer 
containing 0.1 M K2HPO4-KH2PO4,  pH 7.0, 0.01 M  KCI,  1 mM MgSO4, 
and 0.05 M 2-mercaptoethanol. The mixture was centrifuged in a clinical 
centrifuge for 1 min. The cell pellet was suspended in 1 ml Z buffer.  50 
~tl CHCI3 and 20 #! 0.1% SDS were added. The mixture was mixed for 10 
s at maximum speed on a vortex mixer to break the cells. The cell suspen- 
sion was then incubated at 28°C for 2 min. The enzyme substrate o-nitro- 
phenyl-/3-v-galactoside was prewarmed at 28°C. The enzyme reaction was 
started by adding 0.2 ml o-nitrophenyl-/3-v-galactoside  and continued till the 
reaction solution turned to light yellow.  0.5 ml of 1 M  Na2CO3 was then 
added to stop the reaction. Cell debris and CHCI3 were separated from the 
reaction solution by centrifugation. The top clear yellow solution was trans- 
ferred to a new tube and the optical density (OD420) was measured with a 
spectrophotometer. 
Antimycin A-insensitive NADH-Cytochrome C 
Reductase Assay 
The enzyme assay was done according to Sottocassa's procedure (sottocassa 
et al., 1967).  The blank was a mixture of 0.4 ml cytochrome C (0.1 mM), 
0.1 ml KCN (1130 mM), 0.1 ml antimycin A (0.5 mg/50 mi ethanol), 0.5 mi 
buffer (0.1 M K2HPO4-KH2PO4,  10  -4 M EDTA, pH 7.6) and either 10 #l 
mitochondrial suspension or 100/tl cytosol fraction. The blank was moni- 
tored for 1 min for the absorption change. In the assay, everything was the 
same except that 0.1 ml NADH (1 mM) was used and 0.4 ml, instead of 0.5 
ml, buffer was added. The kinetic reaction was measured for l  rain. 
Alcohol Dehydrogenase  Assay 
The assay was used as an assay for cytoplasmic contamination. This assay 
is based on the increase in absorbance at 340 nm which results from the 
reduction of NAD in the presence of alcohol and alcohol dehydrogenase 
(Vallee and Hoch, 1955).  The 10x  reaction mixture contains 160 mM so- 
dium pyrophosphate, pH 8.8, 3.3 M ethanol, and 83.3 mM NAD. Cell ex- 
tracts and water were added to the reaction mixture to a final volume of 3 
ml. The reaction was carried out for 5 min at room temperature and the opti- 
cal density (OD340) was measured with a spectrophotometer. 
RNA Polymerase  Assay 
RNA polymerase was used as a nuclear marker. The assay was done accord- 
ing to the procedure of Winldey et al. (1985).  The reaction mixture contains 
60 mM Tris-HCI, pH 7.9, 2 mM MnCI2, 500/tM UTP, CTE and GTE  10 
ttl ot-[32p]ATP (800 Ci/mmol), 50 mM (NI'L02SO4, 150/zg/ml calf thymus 
DNA and cell extracts to final volume of 40 ~d. The reaction was carded 
out at 300C for 10 min, and stopped by spotting 20/~l of  the reaction mixture 
onto DE81  paper. The remaining steps were based on ~er's  procedure 
(Roeder, 1974).  DE81  filters were immersed in 0.5 M Na2HPO4,  washed 
six times with the same buffer, then washed twice in water, twice in 95 % 
ethanol, and once in ether. The filters were dried and radioactivity was mea- 
sured in a scintillation counter. 
Indirect Immunofluorescence 
Indirect immunofluorescence experiments were carried out according to 
Kilmartin's procedure with some modifications (Kilmartin et al., 1982).  10 
mi of  a culture in early log phase were harvested in a clinical table centrifuge 
for 5 min at maximum speed. Cell pellets were suspended in 5 ml of solu- 
tion A containing 40 mM K2HPO4-KH2PO4,  pH 6.5, and 80 mM MgCI2. 
0.6 ml 37% formaldehyde was added to the suspension to fix cells at room 
temperature for 2 h without shaking. The fixed cells were spun down and 
washed three times with solution B containing 40 mM K2HPO4-KH2PO4, 
pH 6.5, 80 mM MgC12, and 1.2 M sorbitol. Cells were suspended in 1 mi 
solution B. 55/d Glnsulase, 10/~1/~-mercaptoethanol,  and 20 ~tl Zymolyase 
100T (1/~g/~tl in water) were added and the mixture was incubated at 37°C 
for 1 h to make spheroplasts. 
Wells on slides were coated with 0.1% polylysine 400,000  by adding 10 
~tl of  polylysine into each well and removing it by aspiration 10 s later. After 
the wells dried, they were washed three times with water. Spheroplasts were 
washed once with solution B and then suspended in 1 mi solution B.  10-/~1 
spheroplasts were applied into each well and incubated for 20 s. The cell 
suspension was aspirated and the wells were air dried. 10/~1 affinity purified 
antipeptide antibody diluted 1:10 to 1:50 was applied to each well, and in- 
cubated for 1.5 h at room temperature in a moist environment. The primary 
antibody was washed off with eight changes of solution F containing 0.73 
mM KH2PO4,  145 mM NaC1,  and 0.1% BSA.  10/tl of F1TC-conjagated 
second antibody from 1:600 to 1:1,000 dilution was added to each well and 
incubated for another 1.5 h at room temperature in a dark and moist environ- 
merit. Solution F was again changed eight times to remove the secondary 
antibody. For double staining, 20/~1 4',6'-diamidino-2-phenylindole  (DAPI, 
1 #g/mi) was applied to each well and incubated for 1 min. The solution 
was removed and wells were washed once with PBS. Wells were mounted 
with mounting medium and the coverslip was sealed with nail polish. The 
results were analyzed with a Nikon Inc. Biological Microscope OPTIPHOT 
(Garden City, NY). 
The primary antibody was the afffinity-porified antipeptide antibody. The 
secondary antibody was goat anti-rabbit IgG, conjugated with FITC (Cap- 
pel  Laboratories,  Cochranville,  PA).  Nuclear and  mitochondrial DNAs 
were stained by DAPI to serve as location markers for both the nucleus and 
the mitochondria. Anti-/~-galactosidase  antibody was purchased from Wor- 
thington Biochemical Corp. (Freehold, N J) and purified through a/~-gal- 
Sepharose 4B affinity column. 
Results 
The TRM1 Gene  Encodes the m~G-specific tRNA 
Methyltransferase 
We have shown previously that introduction of the  TRM/ 
gene into trml mutant yeast cells restores the ability of the 
mutant to make m22G. Furthermore, expression of the TRM/ 
gene in Escherichia coli  converts that organism into one that 
is able to make this particular base modification (Ellis et al., 
1986). These experiments led us to propose that TRM/en- 
codes m22G-specific tRNA methyltransferase. Here we pres- 
ent two additional experiments that strengthen that conclu- 
sion. First, manipulations which alter the expression of the 
TRM/  gene in yeast alter the level of m2G-specific tRNA 
methyltransferase.  Specifically, the  TRM/  gene was  intro- 
duced into a multicopy plasmid and placed under control of 
the inducible GAL/promoter. This promoter drives increased 
transcription when yeast cells are grown in galactose. Cells 
containing the TRM/gene under GAL/control show a 30- 
fold induction of this specific methyltransferase enzyme ac- 
tivity above the noninduced level found in cells grown in glu- 
cose (Fig.  1). 
A more direct demonstration that the TRM/gene codes for 
the enzyme was obtained by using an antibody raised against 
a synthetic antigen whose sequence was predicted from the 
TRM/ open reading frame (Ellis et al.,  1987).  The TRM/ 
open reading frame predicts a protein of 63 kD and the an- 
tipeptide antibody recognizes a protein of 63 kD (Fig. 2 A, 
lane 1 ). The smaller protein seen at 60 kD in this particular 
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Figure 1. Alteration of TRM1 gene expression alters m~G-specific 
tRNA  methyltransferase  activity.  Methytransferase  activity  was 
measured  in extracts  prepared  from cells  containing  the  vector 
alone and grown in galactose medium (pBM272-gal), or from cells 
containing the pGT554 plasmid derived from pBM272 by cloning 
the TRM/gene under control of the Gall promoter and grown in 
glucose (pGT554-glu) or galactose (pGT554-gal). 
sample is presumably a proteolytic fragment of the 63 kD 
protein as it is not observed in most other preparations. For 
example, it is absent from Fig. 2 A, lane 2,  and B, lane 1. 
The protein in Fig. 2 A, lane 2, was isolated from the original 
trm/mutant while that in Fig. 2 A, lane 3, was from a strain 
of yeast carrying a disrupted allele of the TRM/gene. No 63- 
kD protein was detected in this strain.  The protein in lane 
1 of Fig. 2 B was isolated from cells that produce the TRM1 
product under the control of the GAL/promoter. Wild-type 
cells transformed with the GAL/promoter plasmid without 
the TRM/gene make only wild-type levels of m:2G-specific 
tRNA methyltransferase (detected only on longer exposures 
of the Western blot) compared to cells carrying the  TRM1 
gene on the same vector. This result is consistent with the 
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Anti-pelotlde  Antibody 
Figure 3.  The antipeptide  antibody  inhibits  m~G-specific tRNA 
methyltransferase. Enzyme extracts were incubated for 2 h on ice 
with an invariant amount of total immunoglobin protein. The ratio 
of preimmune to immune IgG in each sample varied. Enzyme ac- 
tivity  was measured  by the  incorporation  of [3H]methyl groups 
from  [3H]methyI-S-adenosyl-L-methionine  into  m2G-deficient 
tRNAs as described  in Materials  and Methods. 
data on the enzyme activity present in Fig.  1. We conclude 
from these experiments that this antibody is specific to the 
TRM/gene product. 
To determine if the protein coded by the TRM1 gene is the 
mEG-specific tRNA methyltransferase, enzyme assays were 
performed in the presence and absence of the antibody. When 
enzyme extracts were incubated with the antipeptide antibody 
before assaying for enzyme activity, enzyme activity was in- 
hibited (Fig. 3). The total amount of protein was kept constant 
in each assay, but the ratio of immune to preimmune IgG was 
increased. Therefore, the increasing inhibition of the enzyme 
activity is specifically caused by an increasing amount of the 
antipeptide antibody used in each assay mixture.  The assay 
was an inhibition assay,  not a precipitation assay so the fact 
that the inhibition never reached  100%  may be explained if 
interaction of the  antibody  with  the  enzyme did  not  cause 
100%  inhibition of activity. 
The m~G-specific tRNA Methyltransferase Is Located 
in the Nucleus 
The m~G-specific tRNA methyltransferase is a mitochondrial 
enzyme responsible for the modification of tRNAs encoded 
by mitochondrial DNA (Ellis et al., 1987). However, the cel- 
lular location for the addition of m~G to cytoplasmic tRNAs 
was not known. To determine whether the methyltransferase 
is located in  nuclei,  cytoplasm, or both,  cell fractionation 
Figure 2.  Identification  of the  TRM/ protein  with  immunoblots 
using the antipeptide  antibody  (A). Lane  1, the wild-type  strain 
W303-1b; lane 2, the trnd mutant strain SNI015-2a; and lane 3, the 
strain W303-1bTHT  which carries a disrupted allele of TRM/. Over- 
production  of the  TRM/ product  from the GALl promoter (B). 
Lane 1, cells carrying TRM/on a multicopy plasmid under the con- 
trol of  the GAL/promoter; lane 2, wild-type cells transformed with 
the GAL/promoter plasmid without the TRM/gene. Upon longer 
exposure, TRMI product is observed in B, lane 2.  100 ttg protein 
was separated on a 10% SDS-PAGE and transferred to nitrocellu- 
lose. The primary antibody was afffinity-purified  antipeptide anti- 
body and the secondary  antibody was affinity-purified goat anti- 
rabbit antibody conjugated with alkaline phosphatase. 
Table L Enzyme Distribution  between the Nucleus 
and Cytoplasm 
Enzyme  Nucleus  Cytoplasm 
%  % 
/~-galactosidase  3  97 
ADHase*  11  89 
RNA polymerase  86  14 
m~Gtase*  84  16 
* Alcohol dehydrogenase. 
* m~G-specific  tRNA methyltransferase. 
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cells carrying the multicopy plasmid HC-3 by indirect 
immunofluorescence.  (a)  The  fluorescent  pattern 
from the DNA-speciflc stain DAPI; and (b) the fluo- 
rescence  pattern  due  to  the  FITC-conjugated goat 
anti-rabbit IgG interacting with the antipeptide anti- 
body. Bar, 10/~m. 
studies  were carried out.  Yeast  nuclei  were isolated from 
wild-type cells by differential centrifugation and purified on 
a  50%  percoll gradient.  As  shown in Table I,  86%  of the 
RNA polymerase activity was associated with the isolated 
nuclei and 14% of this marker enzyme was not nuclear as- 
sociated.  Some of the activity in the nonnuclear fractions 
may arise from the mitochondrial-specific polymerase and 
some from leakage from nuclei. Cytoplasmic contamination 
to the nuclear fraction was assessed by assaying two nonnu- 
clear activities. One is endogenous alcohol dehydrogenase 
activity, the other bacterial/~-gal activity produced from an 
E. coli gene. This latter protein has been shown to be cytoplas- 
mic (Douglas et al.,  1984). Only 3 % of the authentic ~-gal 
and 11% of the alcohol dehydrogenase were associated with 
the isolated nuclei. In the same fractions, 84 % of the m~G- 
specific  tRNA  methyltransferase  activity  from  wild-type 
cells was associated with the nuclear fraction. 
In addition to the cell fractionation studies, we carried out 
indirect immunofluorescence experiments using the antipep- 
tide antibody. We found that the amount of enzyme in wild- 
type cells was below the limit of detection. 
Fig.  4  shows micrographs of cells carrying the plasmid 
HC-3  which  carries  the  wild-type  TRM1  gene  and  thus 
produces protein from both ATGs. Ellis et al. (1986) showed 
that  these  cells produce  10  times  more methyltransferase 
than do wild-type cells and that the vast majority of the pro- 
tein is made from the second ATG. Fig. 4 a  shows a micro- 
graph  of these  cells  stained  with  DAPI,  a  DNA-specific 
fluorescent dye. Fig. 4 b shows the staining pattern observed 
when these cells were treated with the antipeptide antibody 
followed by FITC-conjugated goat anti-rabbit antibodies. A 
comparison of Fig. 4, a and b, shows that the FITC fluores- 
cence outlines the nuclei detected with the DAPI stain.  No 
clear mitochondrial staining  was  detected in these experi- 
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TRM/-~/-gal  fusion  proteins 
by  indirect  immunofluores- 
cence. Cells containing either 
pTRMZ213  (a  and  b)  or 
pTRMZ70 (c and d) were pre- 
pared for indirect immunoflu- 
orescence  and  treated  with 
affinity-purified rabbit anti-/3- 
gal antibody, followed  by FTI-C- 
conjugated anti-rabbit IgG to 
identify the fusion proteins (a 
and c). DAPI was used to stain 
both  nuclear  and  mitochon- 
drial  DNAs  (b and d).  Note 
the  absence  of mitochondri- 
al  DNA  in  cells  carrying 
pTRMZ70. Bar, 20 t~m. 
ments. Cells transformed with Yep24, the vector without the 
TRM1 gene, gave no staining (data not shown). The same ex- 
periment was done with cells carrying pGT554, a  plasmid 
with the  TRM1 gene under control of the  GAL/ promoter. 
When grown in glucose there is no staining but when grown 
in galactose the nuclear targeting is evident (data not shown). 
Both overproducing strains have a staining pattern which is 
most intense around the nuclear periphery resulting  in the 
appearance of a ring-shaped staining pattern. Further analy- 
ses will be necessary to confirm this observation and to begin 
to understand  how it may occur. 
The NH2-terminal 213 Amino Acids of the 
Enzyme Are SuJ~cient to Target [3-Gal to Both Nuclei 
and Mitochondria 
The TRM1 gene has two in-frame ATGs that are both used 
for the initiation of protein synthesis.  The vast majority of 
the TRM1 gene products start from the second ATG and are 
used  to  modify  both  the  mitochondrial  and  cytoplasmic 
tRNAs in wild-type cells (Ellis et al.,  1987). To begin to de- 
termine what sequences within the enzyme can promote the 
proper intracellular localization of the protein,  we created 
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normal promoter was fused to LacZ so proteins starting from 
the first ([1-213 TRM1]/~-gal) or the second ([17-213 TRMII- 
/~-gal) ATG of the gene can be made. A TRM1 gene that had 
the first ATG removed was also fused to LacZ so that only 
the [17-213 TRM1]/~-gal fusion protein would be made. The 
results obtained with both constructions were the same, indi- 
cating that the vast majority of the staining is due to proteins 
beginning at the second ATG. Fig. 5 b shows the DNA stain- 
ing pattern and Fig. 5 a shows the FITC staining pattern ob- 
served in cells containing the fusion gene with both ATGs. 
In this figure, the DAPI and FITC staining appear as dark 
signals against a light background. The protein produced by 
this gene is clearly targeted to both nuclei and mitochondria. 
Genes that produce fusion proteins with fewer amino acids 
derived from the TRM1 gene were derived from those de- 
scribed above. These genes both produced a protein, [17-70 
TRM1]/~-gal,  from the second ATG of the TRM1 gene and 
the gene that retained the first ATG also produces a longer 
protein, [1-70 TRM1]~-gal.  ~-Gal activity in these cells is 
twofold more than those carrying the 213 amino acid fusion. 
As can be seen from comparing Fig. 5, c and d, these pro- 
teins fail to localize ~-gal to the nucleus. Instead, what ~-gal 
can  be  seen  appears  to  be  in  a  few discrete cytoplasmic 
regions. Since cells carrying these fusions have lost their mi- 
tochondrial DNA, and we have not been successful in iden- 
tifying another mitochondrial marker in our studies, we can- 
not determine whether these regions of staining colocalize 
with mitochondria. On the other hand, the fact that the fu- 
sion, but not ~-gal alone, causes loss of mitochondrial DNA 
suggests that the protein is being delivered to the mitochon- 
dria where it interferes in some way with the biogenesis of 
a functional organelle. 
Discussion 
Both mitochondrial and cytoplasmic tRNAs in S.  cerevisiae 
contain m~G and a mutation in the TRM/gene abolishes this 
modification in both tRNA populations. Evidence from ex- 
pression studies of TRM/as well as antibody inhibition exper- 
iments demonstrate that TRM/encodes m~G-specific tRNA 
methyltransferase, the enzyme responsible for the m~G mod- 
ification. The original trml mutant makes a 63-kD protein 
so that a missense mutation or small in-frame deletion must 
be responsible for the lack of enzyme activity in this strain. 
Cell fractionation and indirect immunofluorescence studies 
demonstrate that m2G-specific tRNA methyltransferase is a 
nuclear, not a cytoplasmic, enzyme. A nuclear location for 
this enzyme is consistent with the previous report that pre- 
cursor tRNAs have m~G and are presumably modified inside 
the nucleus (Peebles et al.,  1979; Nishikura and De Rober- 
tis,  1981). These previous experiments did not give insight 
as to whether some enzymes would also be found in the cyto- 
plasm.  In fact, our results suggest that the enzyme is pre- 
dominantly in the nuclei and mitochondria. 
How a protein with two different destinations is sorted in 
the cell is unknown. The observation that the fusion protein 
17-213 TRM1 ~gal is localized to mitochondria and nuclei 
suggests, but does not prove, that sequences important for the 
targeting of the native TRM1 product to dual compartments 
may be located in this region of the protein. Ellis et ai. (1989) 
have constructed fusion proteins between the amino-terminal 
sequences of TRM/and cytochrome oxidase subunit IV or 
dihydrofolate reductase. They found that amino acids  1-48 
and  17-48  coded by the  TRM/  open reading  frame were 
sufficient to target these passenger proteins to the mitochon- 
dria and that the longer TRM/ sequence resulted in more 
efficient import of the fusion proteins. We have not attempted 
to measure the relative efficiency of mitochondrial import of 
the TRM1-/~-gal  fusions and, indeed, have not even demon- 
strated convincingly that the [1-70 TRM1]/[17-70 TRM1]B- 
gal fusions are imported in vivo. Immunofluorescence stain- 
ing appears  concentrated in  a  few distinct regions of the 
cytoplasm but since we have never recovered cells that con- 
tain both the plasmid which directs the synthesis of these fu- 
sions and mitochondrial DNA, we can no longer use DAPI 
staining as a measure of colocalization. Results of cell frac- 
tionation studies show that these fusions do not accumulate 
in the mitochondria (data not shown). The loss of mitochon- 
drial DNA caused by the fusions may be due to a secondary 
consequence of incomplete translocation of TRM1-LacZ fu- 
sion proteins such that the import of other nuclear-coded 
mitochondrial proteins needed for replication, stability, or 
segregation of mitochondrial DNA would be blocked. 
The shorter fusions do not localize to nuclei. If there is not 
a dramatic difference in the stability of the different fusions 
then the region between amino acids 70 and 213 of TRM1 
should contain information sufficient to target/$-gal to nu- 
clei. When comparing this region with known nuclear target- 
ing signals of other nuclear proteins, we find a similarity be- 
tween an amino acid cluster of nine amino acids within this 
region and one of the nuclear targeting signals of the gluco- 
corticoid receptor and the nuclear targeting signal of SV-40 
large T antigen (Picard and Yamamoto,  1987; Kalderon et al., 
1984a,b) as well as histone H2B (Moreland et al.,  1987). In 
fact, seven out of nine amino acids are conserved between 
the  m~G-specific tRNA  methyltransferase and part of the 
nuclear targeting  signal  from the  glucocorticoid receptor 
(Table II).  We have initiated site-directed mutagenesis ex- 
periments to test the hypothesis that this sequence is impor- 
tant to the nuclear localization of native methyltransferase. 
The  m~G-specific tRNA  methyltransferase produced  in 
cells carrying the TRM1 gene on multicopy plasmids appears 
to be concentrated near or at the nuclear membrane. The in- 
direct immunofluorescent staining pattern we observe is dif- 
ferent from the patch-like pore staining and diffuse nucleo- 
plasm  staining  reported for yeast tRNA  ligase (Clark and 
Abelson,  1987)  and the nucleoplasm staining of the yeast 
RNA/1 gene product (Chang et al.,  1988). A concentration 
of staining is observed '~100-300 nm from the nuclear enve- 
lope for these proteins by EM techniques. The staining pat- 
tern of the yeast NSPI gene, at or near the nuclear membrane 
Table II. A Sequence in the Methyltransferase Similar 
to Other Nuclear Targeting Signals 
Nuclear Targeting  Signal  Sequence 
SV-40 large T antigen*  12SPro Pro Lys Lys Lys Arg Lys 132 
Glucocorticoid receptor*  5~°Arg Lys Thr Lys Lys Lys lie Lys  5~7 
Histone H2BI*  3°Lys Lys Arg Lys Ser Lys Ala Lys  38 
Methyltransferase  9SLys Lys Ser Lys Lys Lys Arg Cys j°2 
* Known nuclear  targeting signals. 
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uniform. Recently, Adachi and Yanagida (1989) have observed 
a staining pattern quite similar to that we see with TRM1 an- 
tibodies using antibodies to the crml ÷ (chromosomal region 
maintenance) gene product of S. pombe.  We do not know, 
of course,  whether the m22G-specific tRNA methyltransfer- 
ase in wild-type cells localizes to the periphery of the nu- 
cleus because the level of protein has, so far, precluded our 
detection by the immunofluorescent technique. The question 
of the role that overproduction may play in the subnuclear 
localization we observe cannot be ignored. However, it seems 
less likely to us that overproduction of a protein would con- 
vert it from a nonperipheral to a peripheral protein.  Over- 
production of a known peripheral protein, the tRNA ligase 
in yeast, does result in an increase in nuclear staining away 
from the periphery as if sites  near the membrane become 
saturated (Clark and Abelson, 1987). The fact that the [17-213 
TRM1]/~-gal  fusion protein has a diffuse location throughout 
the nucleus and its synthesis is driven by the wild-type TRM1 
promoter might argue against these ideas on the effects  of 
overproduction. On the other hand, if sequences to the car- 
boxy-terminal side of amino acid 213  are needed  for sub- 
nuclear localization of native TRM1, they would be missing 
from this fusion. That sequences direct the subnuclear loca- 
tion of nuclear proteins has been demonstrated by Siomi et al. 
0988).  The first 20 amino acids of human T cell leukemia 
virus type I p27  ~'" are sufficient to localize/$-gal in the nu- 
cleolus.  This  region must,  by itself,  constitute a  structure 
that is recognized by the nuclear transport machinery and 
that  once  imported  interacts  with  nucleolar  components. 
Longer TRMI-LacZ fusions that could be useful in locating 
a  subnuclear  localization  signal  are  currently  being  con- 
structed. 
Although there are quite a few proteins now identified that 
are shared by the mitochondria and the cytoplasm (Beltzer 
et al., 1986; Natsoulis et al., 1986; Wu and Tzagoloff, 1987; 
Chatton et al., 1988; Gillman, E. C., L. Slusher, N. C. Mar- 
tin,  and A.  K.  Hopper,  unpublished observations),  m,2G  - 
specific tRNA methyltransferase  is the only one to our knowl- 
edge that is shared by the mitochondria and the nucleus. As 
such, it presents a unique opportunity to ask how a single 
protein is sorted to both compartments.  In addition, while 
the  TRM/  gene is  now well characterized,  little is known 
about the function of m~G modification on tRNAs and why 
the enzyme responsible for this base modification is located 
in  the nucleus.  Further analyses  promise  to  increase  our 
knowledge about both of these questions. 
Our  thanks  to  Dr.  Robert  Moreland  for  helping  us  begin  our  im- 
munofluorescence  studies. 
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References 
Adachi,  Y., and M.  Yanagida.  1989. Higher order chromosome structure  is 
affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene 
crml  + which encodes a  115-kD protein preferentially  localized in the nu- 
cleus and at its periphery.  J.  Cell Biol. 108:1195-1207. 
Beltzer, J. P., L.-F. L. Chang, A. G. Hinkkanen, and G. B. Kohlhaw.  1986. 
Structure of yeast LEU4: the 5' flanking region contains features that predict 
two modes of control and two productive translation starts. J.  Biol. Chem, 
261:160-167. 
Bjork, G. R., and 1. Svensson.  1969. Studies on microbial RNA. Eur. J. Bio- 
chem. 9:207-215. 
Bradford,  M.  M.  1976. A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye bind- 
ing. Anal.  Biochem.  72:248-254. 
Chang, T. H., M. W. Clark, A. J. Lustig, M. E. Cusick, andJ. Abelson. 1988. 
RNAI 1 protein is associated with the yeast spliceosome and is localized in 
the periphery  of the cell nucleus, biol.  Cell. Biol. 8:2379-2393. 
Chanon, B., P. Walter, J. P. Ebel, F. Lacrnute, and F. Fasiolo. 1988. The yeast 
VASI gene encodes both mitochondrial and cytoplasmic valyl-tRNA synthe- 
rases. J.  Biol. Chem. 263:52-57. 
Clark,  M. W., and J. Abelson.  1987. The subnuclear localization of tRNA li- 
gase in yeast. J.  Cell Biol. 105:1515-1526. 
Douglas, M. G., B. L. Geller, and S. D. Emr. 1984. Intracellular targeting and 
import of an F I-ATPase/3-subunit-/3-galactosidase hybrid protein into yeast 
mitochondria. Proc.  Natl. Acad.  Sci. USA. 81:3983-3987. 
Ellis, S. R., A. K. Hopper, and N. C. Martin.  1987. Amino-terminal extension 
generated from an upstream AUG codon is not required for mitochondrial 
import of yeast N2,N2-dimethylguanosine-specific  tRNA methyhransferase. 
Proc. Natl. Acad. Sci. USA. 84:5172-5176. 
Ellis, S. R., A. K. Hopper, and N. C. Martin.  1989. Amino-terminal extension 
generated from an upstream AUG codon increases the efl%iency of mito- 
chondrial import of yeast N2,N2-dimethylguanosine-specific tRNA methyl- 
transferases.  Mol. Cell. Biol. 9:1013-1028. 
Ellis, S. R., M. J. Morales, J. M. Li, A. K. Hopper, and N. C. Martin.  1986. 
Isolation and characterization  of the  TRMI  locus, a gene essential  for the 
N~,NZ-dimethylguanosine modification of both mitocbondrial and cytoplas- 
mic tRNA in Saccharomyces cerevisiae.  J.  Biol. Chem. 261:9703-9709. 
Emr,  S.  D., A. Vassarntti, J. Garrett,  B.  L. Geller,  M. Takeda,  and M. G. 
Douglas.  1986. The  amino  terminus  of the  yeast  FI-ATPase /3-subunit 
precursor functions as a mitochondrial import signal. J. Cell Biol.  102:523- 
533. 
Guarente,  L., R. Yocum, and P. Gifford.  1982. A GALIO-CYCI hybrid yeast 
promoter  identifies the GAL4 regulatory  region as an upstream site. Proc. 
Natl. Acad. Sci. USA. 79:7410-7414. 
Hopper, A. K., A. H. Furukawa, H. D. Pham, and N. C. Martin. 1982. Defects 
in modification of cytoplasmic and mitochondrial transfer RNAs are caused 
by single nuclear mutations.  Cell. 28:543-550. 
Hurt, E. C.  1988. A novel nucleoskeletal-like protein located at the nuclear pe- 
riphery is required for the life cycle of Saccharomyces cerevisiae.  EMBO 
(Eur. Mol. Biol. Organ.)J.  7:4323--4334. 
Ito, H., Y. Fukuda, K. Murata, and A. Kimura.  1983. Transformation of intact 
yeast cells treated with alkali cations. J.  Bacteriol.  153:163-168. 
Johnston,  M., and R. W. Davis.  1984. Sequences that regulate the divergent 
GALI-GALIO  promoter  in  Saccharomyces  cerevisiae.  Mol. Cell. Biol. 
4:1440-1448. 
Kalderon, D., W. D. Richardson,  A. E. Markham, and A. E. Smith.  1984a. 
Sequence requirements for nuclear location of simian virus 40 large-T anti- 
gen. Nature  (Lond.).  311:33-38. 
Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith.  1984b. A 
short amino acid sequence able to specify nuclear location.  Cell. 39:499- 
509. 
Kilmartin, J. V., B. Wright, and C. Milstein. 1982. Rat monoclonal antitubulin 
antibodies derived by using a new nonseereting rat cell line. J.  Cell Biol. 
93:576-582. 
Lerner, R. A., N. Green, H. Alexander, F.-T. Liu, J. G. Sutcliffe, and T. M. 
Shinnick.  1981. Chemically synthesized peptides predicted from the nucleo- 
tide sequence of the hepatitis B virus genome elicit antibodies reactive with 
the native envelope protein of Dane particles. Proc. Natl. Acad.  Sci. USA. 
78:3403-3407. 
Livingston, D. M. 1974. Immunoaflinity chromatography of proteins. Methods 
Enzymol.  34:723-731. 
Martin, R. P., J. M. Schneller, A. J. C. Stahl, andG. Dirheimer.  1976. Studies 
of odd  bases in yeast  mitocbondrial  tRNA.  II. Characterization  of rate 
nucleosides. Biochem. Biophys.  Res.  Commun. 70:997-1002. 
Miller, J. H.  1972. Experiments in Molecular Genetics. Cold Spring Harbor 
Laboratory,  Cold Spring Harbor,  NY.  352-353. 
Moreland,  R. B., G.  L.  Langevin,  R.  H.  Singer,  R. L.  Oarcea,  and L.  M. 
Hereford.  1987. Amino acid sequences that determine the nuclear localiza- 
tion of yeast historic 2B. Mol. Cell. Biol. 7:4048--4057. 
Natsoulis, G., F. Hilger,  and G. R. Fink.  1986. the HTSI gene encodes both 
the cytoplasmic and mitocbondrial histidine tRNA synthetase of S. cerevisiae. 
Cell. 46:235-243. 
Nan, F.  1976. The methylation of tRNA.  Biochimie  (Paris). 58:629-645. 
Nishikuru, K., and E. M. De Robertis.  1981. RNA processing in microinjecled 
Xenopus  oocytes,  sequential  addition  of base  modifications  in  a  spliced 
tRNA. J.  Mol. Biol. 145:405--420. 
Peebles, C. L., R. C. Ogden, G. Knapp, and J. Abelson. 1979. Splicing of  yeast 
tRNA precursors:  a two-stage reaction.  Cell. 18:27-35. 
Picard,  D.,  and  K.  R.  Yamamoto.  1987. Two  signals  mediate  hormone- 
dependent nuclear localization of the glucocorticoid receptor. EMBO (Eur. 
Mol.  Biol. Organ.)J.  6:3333-3340. 
Roeder, R. G.  1974. Multiple forms of deoxyribonucleic acid-dependent ribo- 
nucleic acid polymerase  in Xenopus laevis. J Biol.  Chem. 249:241-248. 
Sanger, F., S. Nicklen, and A. R. Coulson.  1977. DNA sequencing with chain- 
terminating  inhibitors.  Proc. Natl. Acad. Sci. USA. 74:5463-5467. 
Silver, P. A., L. P. Keegan, and M. Ptashne. 1984. Amino terminus oftbe yeast 
GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. 
Sci.  USA. 81:5951-5955. 
The Journal of Cell Biology, Volume  109, 1989  1418 Siomi, H., H. Shida, S. H. Nam, T. Nosaka, M. Maki, and M.  Hatamaka. 
1988.  Sequence requirements for nucleolar localization of human T  cell 
leukemia virus type I pX protein, which regulates viral RNA processing. 
Cell. 55:197-209. 
Sottocassa, G. L., B. Kuylenstierua, L. Eruster, and A. Bergstrand. 1967. An 
electron-transport system associated with the outer membrane of liver mito- 
chondria. J.  Cell Biol. 32:415-438. 
Tobin, H., T. Stuehelin, and J. Gordon. 1979. Electrophoretic transfer of pro- 
teins from polyacrylamide gels to nitrocellulose sheets: procedure and some 
applications. Proc.  Natl. Acad.  Sci. USA. 76:4350-4354. 
Vallee, B. L., and F. L. Hoch. 1955.  Zinc, a component of yeast alcohol de- 
hydrogenase. Proc. Natl. Acad.  Sci. USA. 41:327-328. 
Winkley, C. S., M. J. Keller, and J. A. Jaehning. 1985. A multicomponent mi- 
tochondrial  RNA  polymerase  from  Saccharomyces  cerevisiae.  J.  Biol. 
Chem. 260:14214-14223. 
Wu, M., and A. Tzagoloff. 1987. Mitochondrial and cytoplasmic fumerases in 
Saccharomyces cerevisiae are encoded by a single nuclear gene FUM1. J. 
Biol.  Chem. 262:12275-12282. 
Zakian, V. A., and J. F. Scott.  1982. Construction, replication, and chromatin 
structure of TRPI RI circle, a multiple-copy synthetic plasmid derived from 
Saccharomyces cerevisiae chromosomal DNA. Mol. Cell. Biol. 2:221-232. 
Li et al. Nuclear Location of Yeast tRNA Methyltransferase  1419 